InEmpathy Charity

BraineHealth’s InEmpathy initiative uses US Patent 11,908,579 B2 and Diagnosio’s 99% accurate AI diagnostics to support underserved communities.

Our inversion technology, featured in USA News, BizWeekly and AP across 450+ outlets, scales to 20,000+ cases, aligning with global health equity. Outperforming Microsoft’s MAI-DxO, it drives the $500B AI market by 2032.

Join our mission through licensing or partnership.

Impact Areas:

Health Access: AI diagnostics for remote areas.

Charitable Reach: Supporting global well-being.

License the Patent | Contact Us to collaborate.